(OTCQB: BIXT) (the "Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, stroke, dementia, and Alzheimer's disease, announced its ...

Hawaii airports have a 44% survival rate for cardiac arrests, thanks to AEDs. Free CPR and AED training is available at ...

Patients with HR+/HER2− metastatic breast cancer without previous systemic therapy were randomly assigned to receive either ...

Daiichi Sankyo's stock dropped 25% due to disappointing clinical data, but upcoming studies could drive a rebound for ...

The ASIR (per 100,000 person-years) of testicular germ cell tumors increased from 4.71 in 1992 to 6.22 in 2021, for an average annual percent change (AAPC) of 0.92%. The ASIR of seminoma increased ...

In early 2024, the World Health Organization predicted that by 2050 there will be more than 35 million new cancer cases ...

The Million Fruit Trees Plantation (MFTP) project has completed its third phase, generating over Nu 1 million in revenue from ...

A study led by Dr. Fengyu Wen from the Institute of Medical Technology at Peking University Health Science Center and Professor Luxia Zhang from the National Institute of Health Data Science at Peking ...

Pump-Action Shotgun is your best friend when things get up close and personal. It deals an impressive 220 damage per shot, ...

The FDA granted orphan drug designation to amezalpat in hepatocellular carcinoma based on phase 1b/2 data showing efficacy ...

A study by Joseph J. Mangano, an epidemiologist with the Radiation and Public Health Project, sheds light on the impact of ...

The epaulette shark’s ability to “walk” on land gives it a distinct survival advantage and traces its lineage back to the ...